These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11379847)

  • 1. Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.
    Hough DW
    J Clin Psychiatry; 2001 Apr; 62(4):296-7. PubMed ID: 11379847
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
    Crocq MA; Leclercq P; Guillon MS; Bailey PE
    Eur Psychiatry; 2002 Sep; 17(5):296-7. PubMed ID: 12381502
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.
    Grant JE
    J Clin Psychiatry; 2001 Apr; 62(4):297-8. PubMed ID: 11379848
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.
    Martín JC; Palenciano G; Pérez R
    J Clin Psychiatry; 2000 Dec; 61(12):948. PubMed ID: 11206602
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of high-dose olanzapine in refractory psychosis.
    Reich J
    Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical antipsychotics and cognition in schizophrenia.
    Sharma T
    Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
    Schulz SC; Camlin KL; Berry SA; Jesberger JA
    Biol Psychiatry; 1999 Nov; 46(10):1429-35. PubMed ID: 10578457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study.
    Zanarini MC; Frankenburg FR
    J Clin Psychiatry; 2001 Nov; 62(11):849-54. PubMed ID: 11775043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose olanzapine therapy in schizophrenia.
    Alao AO; Armenta WA; Yolles JC
    Ann Pharmacother; 1999 Nov; 33(11):1228. PubMed ID: 10573326
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine-induced manic-like syndrome.
    Lindenmayer JP; Klebanov R
    J Clin Psychiatry; 1998 Jun; 59(6):318-9. PubMed ID: 9671347
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine for cocaine craving and relapse prevention in 2 patients.
    Longo LP
    J Clin Psychiatry; 2002 Jul; 63(7):595-6. PubMed ID: 12143917
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
    Detweiler MB; Trinkle DB
    J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose olanzapine in an adolescent.
    Heimann SW
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):496-8. PubMed ID: 10230177
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of olanzapine, as needed, to treat acute agitation in juveniles.
    Sheikh RM; Ahmed K
    J Child Adolesc Psychopharmacol; 2002; 12(1):71-3. PubMed ID: 12014599
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.
    Soler J; Pascual JC; Campins J; Barrachina J; Puigdemont D; Alvarez E; Pérez V
    Am J Psychiatry; 2005 Jun; 162(6):1221-4. PubMed ID: 15930077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of self-mutilation in a patient with borderline personality during risperidone therapy.
    Khouzam HR; Donnelly NJ
    J Nerv Ment Dis; 1997 May; 185(5):348-9. PubMed ID: 9171814
    [No Abstract]   [Full Text] [Related]  

  • 20. Polypharmacy of 2 atypical antipsychotics.
    Rhoads E
    J Clin Psychiatry; 2000 Sep; 61(9):678-80. PubMed ID: 11030491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.